Accord Biopharma recalls

Accord Biopharma has 1 recall on record with the FDA and USDA, the earliest in 2026 and the latest reported on 8 Jul 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is sterility.

Total recalls1since 2026
Last 12 months1reported
Class I00% of total
Ongoing1latest 8 Jul 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why accord biopharma is recalled

Product types

By year

Ongoing accord biopharma recalls

1 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIImuldosa, (ustekinumab-srlf) Injection, 130 mg/ (5mg/mL) recalledImuldosaAccord BiopharmaSterilityNationwide

All accord biopharma recalls, newest first

1 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIImuldosa, (ustekinumab-srlf) Injection, 130 mg/ (5mg/mL) recalledImuldosaAccord BiopharmaSterilityNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.